However, the time needed for skeletal muscle adaptation following pharmacotherapy in these patients is unclear, with ACE inhibitor treatment duration ranging from 10 weeks to 12 months for studies of improved 6-min walk distance in heart failure.27 The potential role of longer-term therapy remains to be evaluated in further trials. The gene discussed is ACE; the disease is heart failure.